ATP Life Science Ventures, L.P. 13F Holdings · last filed Q1 2021
ATP Life Science Ventures, L.P. reported 3 securities worth $898.30M in its SEC 13F filing for Q1 2021 (period ended 2021-03-31). Top holdings: STOK (74.20%), AKRO (18.83%), KDNY (6.97%).
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | STOK | Stoke Therapeutics, Inc. | $666.6M | 74.20% | 17.2M | Hold |
| 2 | AKRO | Akero Therapeutics, Inc. | $169.1M | 18.83% | 5.8M | Hold |
| 3 | KDNY | Chinook Therapeutics, Inc. | $62.6M | 6.97% | 4.0M | Hold |
Source: SEC Form 13F filings · as of 2021-03-31
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR